MUC4 and neoplasm: This commercially available (Rockland Immunochemicals) mAb was shown to specifically stain PDAC tissue, bind tumor cells expressing aberrant MUC4, and maintain its specificity against a panel of many TFag-containing molecules on much larger glycan microarrays with a much broader range of components [36].